Secondary prevention strategies following tongue cancer include monthly follow-ups for the first 12-18 months following therapy. Drugs such as synthetic retinoids, non-steroidal antiinflammatory drugs, EGFR inhibition, and human papilloma virus related oropharyngeal carcinoma vaccine can be used as a secondary chemopreventive agents.
Tongue cancer secondary prevention
Oral cancer primary prevention
Laryngeal cancer secondary prevention
Oral cancer secondary prevention
Laryngeal cancer primary prevention
Tongue cancer risk factors
Salivary gland tumor secondary prevention
Tongue cancer surgery